Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
13-valent pneumococcal conjugate vaccine antibody levels in children with clinical pneumonia
CTR20181825Phase 4Completed
- Sponsor
- Pfizer
- Start
- Jan 2019
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of pneumococcal 13-valent conjugate vaccine in pneumonia, sponsored by Pfizer. Started Jan 2019; status: completed.
02
Drugs
pneumococcal 13-valent conjugate vaccine
03
Conditions
pneumonia
Beyond the preview
Go deeper on CTR20181825.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20181825.